Clinical Trial Update: Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated BIA 9-1067 and its metabolites in healthy elderly and healthy young male subjects; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2015-01-14